- Risk factors for rib metastases of lung cancer patients with high-uptake rib foci on 99Tcm-MDP SPECT/CT
Yuanyuan YANG et al, 2024, The Quarterly Journal of Nuclear Medicine and Molecular Imaging CrossRef - The road of NSCLC stem cells toward bone metastases
Giulia Bertolini et al, 2022, Bone Reports CrossRef - Immune Checkpoint Inhibitor Therapy for Bone Metastases: Specific Microenvironment and Current Situation
Chang Liu et al, 2021, Journal of Immunology Research CrossRef - Novel predictors of immune checkpoint inhibitor response and prognosis in advanced non‐small‐cell lung cancer with bone metastasis
Yohei Asano et al, 2023, Cancer Medicine CrossRef - Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer
Annalise G. Abbott et al, 2024, Frontiers in Immunology CrossRef - Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review)
Toru Hiraga, 2024, International Journal of Oncology CrossRef - Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients
Andrea De Giglio et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef - A Case of Metastatic Submandibular Salivary Duct Carcinoma that Completely Responded to Pembrolizumab Monotherapy
Masashi Nakaishi et al, 2023, Journal of Nippon Medical School CrossRef - Bone Cancer Pain, Mechanism and Treatment
Sonny Hermanus Johannes Sliepen, 2021, Recent Advances in Bone Tumours and Osteoarthritis CrossRef - Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment
Nan Sethakorn et al, 2022, Cancers CrossRef - Response rate specific to bone metastasis of various cancers for immune checkpoint inhibitors: a systematic review
Shinji Tsukamoto et al, 2024, European Journal of Orthopaedic Surgery & Traumatology CrossRef - Immunotherapy for sarcomas
Eiji Nakata et al, 2021, Japanese Journal of Clinical Oncology CrossRef